Budget Reductions Target FDA Field Operations
This article was originally published in The Tan Sheet
Executive Summary
President Obama’s fiscal 2016 budget request includes cuts to “low priority” enforcement, surveillance and other activities in the FDA human drugs and biologics programs, but still increases drug and biologics program budgets overall.